NIVFNasdaqServices-Misc Health & Allied Services, NECAlso trades as NIVFW
NewGenIvf Group Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026
$0.28+0.00 (+1.47%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 0.1
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
NewGenIvf has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements NewGenIvf filed with the SEC
PRESS RELEASE, DATED SEPTEMBER 28, 2026
EX-99.1 to Form 6-K
PRESS RELEASE, DATED SEPTEMBER 30, 2026
EX-99.2 to Form 6-K
Exchange of Convertible Notes with Institutional Investor
EX-99.1 to Form 6-K
NewGen Provides Update on K25.ai Investment
EX-99.1 to Form 6-K
NewGen to Acquire Additional 3% of K25.ai at
EX-99.1 to Form 6-K
NewGen Issues 3,666,667 New Shares in Connection
EX-99.1 to Form 6-K
NewGen Eliminates Convertible Note and Warrant
EX-99.1 to Form 6-K
NewGen Doubles Down on K25.ai with Additional
EX-99.1 to Form 6-K
NewGen Executes Share Purchase Agreement and
EX-99.1 to Form 6-K
NewGenIVF Announces Strategic Investment Agreement
EX-99.1 to Form 6-K
NEWGEN REPORTS NINE-MONTH 2025 RESULTS
EX-99.1 to Form 6-K
NEWGEN ANNOUNCES UP TO US$2 MILLION SHARE REPURCHASE PROGRAM
EX-99.1 to Form 6-K
NewGen Subsidiary Signs Memorandum of Understanding
EX-99.1 to Form 6-K
NewGen Subsidiary Secures Strategic UAE
EX-99.1 to Form 6-K
NewGen Announces Planned $30 Million Strategic
EX-99.1 to Form 6-K
NewGen’s ordinary shares to begin trading
EX-99.1 to Form 6-K
Acquisition of MicroSort Reproductive Technology
EX-99.1 to Form 6-K
Receives Nasdaq Delisting Notice and Plans to Submit
EX-99.1 to Form 6-K
NewGenIvf Enters into a Binding Term
EX-99.1 to Form 6-K
NewGenIvf Signs Non-Binding Term Sheet for
EX-99.1 to Form 6-K
NewGenIvf Receives Nasdaq Notifications Regarding
EX-99.1 to Form 6-K
This summary of terms (“Term Sheet”)
EX-99.1 to Form 6-K